- Home
- ESPR vs FRA Comparison
ESPR vs FRA Comparison
Compare ESPR & FRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- FRA
- Stock Information
- Founded
- ESPR 2008
- FRA 2003
- Country
- ESPR United States
- FRA United States
- Employees
- ESPR N/A
- FRA N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- FRA Investment Bankers/Brokers/Service
- Sector
- ESPR Health Care
- FRA Finance
- Exchange
- ESPR Nasdaq
- FRA Nasdaq
- Market Cap
- ESPR 534.3M
- FRA 464.9M
- IPO Year
- ESPR 2013
- FRA N/A
- Fundamental
- Price
- ESPR $2.55
- FRA $13.02
- Analyst Decision
- ESPR Buy
- FRA
- Analyst Count
- ESPR 6
- FRA 0
- Target Price
- ESPR $6.50
- FRA N/A
- AVG Volume (30 Days)
- ESPR 7.0M
- FRA 165.4K
- Earning Date
- ESPR 11-06-2025
- FRA 01-01-0001
- Dividend Yield
- ESPR N/A
- FRA 11.06%
- EPS Growth
- ESPR N/A
- FRA N/A
- EPS
- ESPR N/A
- FRA N/A
- Revenue
- ESPR $268,125,000.00
- FRA N/A
- Revenue This Year
- ESPR $13.05
- FRA N/A
- Revenue Next Year
- ESPR N/A
- FRA N/A
- P/E Ratio
- ESPR N/A
- FRA N/A
- Revenue Growth
- ESPR N/A
- FRA N/A
- 52 Week Low
- ESPR $0.69
- FRA $11.33
- 52 Week High
- ESPR $3.94
- FRA $13.10
- Technical
- Relative Strength Index (RSI)
- ESPR 47.71
- FRA 44.47
- Support Level
- ESPR $2.35
- FRA $12.61
- Resistance Level
- ESPR $3.41
- FRA $13.01
- Average True Range (ATR)
- ESPR 0.18
- FRA 0.10
- MACD
- ESPR -0.03
- FRA -0.01
- Stochastic Oscillator
- ESPR 9.79
- FRA 66.07
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About FRA Blackrock Floating Rate Income Strategies Fund Inc
Blackrock Floating Rate Inc Stra Fd Inc is a United States-based diversified closed-ended management investment company. The Fund's investment objective is to provide shareholders with high current income and preservation of capital with investment in a diversified, leveraged portfolio consisting of floating-rate debt securities and instruments.